Palmitoylation of human FasL modulates its cell death-inducing function

por Guardiola-Serrano, F, Rossin, A, Cahuzac, N, Lückerath, K, Melzer, I, Mailfert, S, Marguet, D, Zörnig, M, Hueber, A-O
Publicado 2010

ALIGNed on adherence: subanalysis of adherence in immune‐mediated inflammatory diseases in the DACH region of the global ALIGN study

por Kolios, A.G.A., Hueber, A.J., Michetti, P., Mrowietz, U., Mustak‐Blagusz, M., Sator, P.‐G., Reinshagen, M., Wilsmann‐Theis, D., Gomis‐Kleindienst, S., Luckey, U., Rössler, A., Schiefke, I.
Publicado 2018

No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis

por Kienhöfer, D., Hahn, J., Schubert, I., Reinwald, C., Ipseiz, N., Lang, S. C., Borràs, È. Bosch, Amann, K., Sjöwall, C., Barron, A. E., Hueber, A. J., Agerberth, B., Schett, G., Hoffmann, M. H.
Publicado 2014

Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study

por Schenker, H.M., Tascilar, K., Konerth, L., Sergeeva, M., Prade, J., Strobelt, S., Kleyer, A., Simon, D., Mendez, L., Hagen, M., Schönau, V., Hueber, A., Roesch, J., Dörfler, A., Hess, A., Schett, G., Rech, J.
Publicado 2021

Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528]

por González, R., Rodríguez-Hernández, M.A., Negrete, M., Ranguelova, K., Rossin, A., Choya-Foces, C., de la Cruz-Ojeda, P., Miranda-Vizuete, A., Martínez-Ruiz, A., Rius-Pérez, S., Sastre, J., Bárcena, J.A., Hueber, A.-O., Padilla, C.A., Muntané, J.
Publicado 2023